Top news of the week: 21.07.2020.

#news #pharma #pharmiweb #biotechnology #scichat #edtech #synbio #STEMed #biochat #STEM

Career And Jobs

On Jul 17, 2020
@pharminews shared
PureTech Founded Entity Vor Biopharma Appoints Daniella Beckman to its Board of Directors https://t.co/emfFJISTRA #news #pharma #pharmiweb
Open

PureTech Founded Entity Vor Biopharma Appoints Daniella Beckman to its Board of Directors

PureTech Founded Entity Vor Biopharma Appoints Daniella Beckman to its Board of Directors

PureTech Health plc (LSE: PRTC) (“PureTech” or the “Company”), a clinical-stage biotherapeutics company dedicated to discovering, developing and commercialising ...

On Jul 20, 2020
@SynBioBeta shared
RT @JustOneGiantLab: Amino Labs' mission is to enable millions to learn and practice #biotechnology to become bio-artists, bio-engineers, bio-enthusiasts, or simply become bio-literate. Great interview with Julie Legault: https://t.co/vaHByHn9da #synbio #STEMed #STEM #edtech #scichat #biochat #synbio https://t.co/NCNu4n9xBm
Open
On Jul 20, 2020
@pharminews shared
British Patient Capital commits $65m to SV Health Investors, to invest in life-changing biotechnology companies https://t.co/pW7jwew167 #news #pharma #pharmiweb
Open

British Patient Capital commits $65m to SV Health Investors, to invest in life-changing biotechnology companies

British Patient Capital commits $65m to SV Health Investors, to invest in life-changing biotechnology companies

SV Health Investors closes first fund dedicated to biotechnology at $265mInvestment builds on British Patient Capital’s current commitments to life sciences 20th July 2020 ...

On Jul 16, 2020
@JohnCendpts shared
ex-Kala: GSK’s Shingrix leader Guillaume Pfefer has jumped on board Flagship to helm a biotech hybrid as Afeyan’s latest CEO-partner https://t.co/lek14RnB3L
Open

GSK’s Shingrix leader Guillaume Pfefer has jumped on board Flagship to helm a biotech hybrid as Afeyan’s latest CEO-partner

GSK’s Shingrix leader Guillaume Pfefer has jumped on board Flagship to helm a biotech hybrid as Afeyan’s latest CEO-partner

After spending 4 years in a senior post with GlaxoSmithKline’s star team positioning Shingrix for a blockbuster approval, Guillaume Pfefer is headed back to the biotech world — in style. ...

On Jul 17, 2020
@FierceBiotech shared
Principia was the subject of the ire of Sahm Adrangi's Kerrisdale Capital, which in January trained its sights on the biotech, arguing the pipeline of the Sanofi partner is “worthless.” https://t.co/5eKugtRA78
Open

Sanofi has a $50B biotech buyout budget, with Principia top of the list: report

Sanofi has a $50B biotech buyout budget, with Principia top of the list: report

Still augmenting its R&D and trying to drive innovation internally, French Big Pharma Sanofi is preparing to spend billions on biotechs to help further this cause.

On Jul 15, 2020
@pharminews shared
PureTech Founded Entity Vor Biopharma Raises $110 Million in Series B Financing https://t.co/PZ4ZusEAEi #news #pharma #pharmiweb
Open

PureTech Founded Entity Vor Biopharma Raises $110 Million in Series B Financing

PureTech Founded Entity Vor Biopharma Raises $110 Million in Series B Financing

Proceeds will advance the company’s lead programme into clinical trials and expand the portfolio Financing led by RA Capital Management, with Participation from Fidelity ...

On Jul 15, 2020
@CMichaelGibson shared
My comments on @Boston25 News last night here: First experimental COVID-19 vaccine created by Mass. biotech company, NIH shows promising results https://t.co/y13OpHgHP1
Open

First experimental COVID-19 vaccine created by Mass. biotech company, NIH shows promising results

First experimental COVID-19 vaccine created by Mass. biotech company, NIH shows promising results

The first COVID-19 vaccine tested in the U.S. revved up people’s immune systems just the way scientists had hoped, researchers reported Tuesday -- as the shots are poised to begin key final ...

On Jul 17, 2020
@pharminews shared
MARINOMED BIOTECH AG: CARRAGELOSE® EFFECTIVE AGAINST SARS-CoV-2 IN CELL CULTURE ASSAYS https://t.co/YVDiguz1SW #news #pharma #pharmiweb
Open

MARINOMED BIOTECH AG: CARRAGELOSE® EFFECTIVE AGAINST SARS-CoV-2 IN CELL CULTURE ASSAYS

MARINOMED BIOTECH AG: CARRAGELOSE® EFFECTIVE AGAINST SARS-CoV-2 IN CELL CULTURE ASSAYS

Korneuburg/Vienna, 16th July 2020. Marinomed Biotech AG announces that pre-clinical data show that Carragelose® has the potential to reduce the risk of an infection with SARS-CoV-2 and ...